Company:  ORAMED PHARMACEUTICALS IN ... (ORMP)
Form Type:  8-K
Filing Date:  2/12/2014 
CIK:  0001176309 
Address:  HI-TECH PARK 2/4 GIVAT-RAM
PO BOX 39098
 
City, State, Zip:  JERUSALEM,  91390 
Telephone:  011 972-2-566-0001 
Fiscal Year:  08/31 
Last Trade
Last Trade: 
$7.62  
Change: 
0.02 (0.26%)  
Trade Time: 
Aug 26  
Market Cap: 
$100.10M
Trade ORMP now with 

© 2016  
Description of Business
We are a pharmaceutical company currently engaged in the research and development of innovative pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. Oral insulin: We are seeking to revolutionize the treatment of diabetes through our proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801). Having completed Phase IIa clinical trials in patients with both type 1 and type 2 diabetes, we initiated a Phase IIb clinical trial on approximately 180 type 2 diabetic patients that is being conducted in approximately 30 sites in the United States, beginning in June 2015. This double-blind, randomized, 28-day study clinical trial is conducted under an Investigational New Drug application, or IND, with the U.S. Food and Drug Administration, or FDA.
Register and access this filing in:     
  FORM 8-K
    SECTION 7 REGULATION FD
      ITEM 7.01. REGULATION FD DISCLOSURE.
    SECTION 8 OTHER EVENTS
      ITEM 8.01. OTHER EVENTS.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
    SIGNATURES
  EXHIBIT 99
  EXHIBIT 99